Stocks Health care PTCT
NASDAQ · Health carePtc Therapeutics, Inc. (PTCT)
Ptc Therapeutics, Inc. brought in $1B of revenue over the twelve months to June 30, 2026, down 42.8% from a year earlier. It posted a net loss of $38.4M. Operating cash flow minus capital spending left $702.3M of free cash flow in fiscal 2025. At June 30, 2026 it held $1B in cash against $591M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.
What Ptc Therapeutics, Inc. does
Ptc Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PTCT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.7B | $682.6M | $7.78 | $702.3M |
| 2024 | $806.8M | -$363.3M | -$4.73 | -$114.2M |
| 2023 | $937.8M | -$626.6M | -$8.37 | -$186.9M |
| 2022 | $698.8M | -$559M | -$7.79 | -$388.7M |
| 2021 | $538.6M | -$523.9M | -$7.43 | -$279.5M |
| 2020 | $380.8M | -$438.2M | -$6.64 | -$211.9M |
Latest SEC filings
What Ptc Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 21, 2026
- August 28, 2026
- August 13, 2026
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026
- July 30, 2026
- June 18, 2026
- June 16, 2026Other event 8-K
- June 9, 2026
- June 5, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about PTCT
What does Ptc Therapeutics, Inc. do?
Ptc Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PTCT.
Is Ptc Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $38.4M on revenue of $1B.
How much revenue does Ptc Therapeutics, Inc. make?
Over the twelve months to June 30, 2026 Ptc Therapeutics, Inc. reported revenue of $1B. That is 42.8% less than a year earlier.
When did Ptc Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 21, 2026.
Similar companies
Follow PTCT
Get an email when Ptc Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PTCT: get an email when it filesWhere the numbers come from
Financial figures are the values Ptc Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.